Screener
Integra LifeSciences IART Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
FAQ
- What is Integra LifeSciences's enterprise value?
- Integra LifeSciences (IART) reported enterprise value of $3.15B in Q2 2026.
- How has Integra LifeSciences's enterprise value changed year-over-year?
- Integra LifeSciences's enterprise value increased by 20.7% year-over-year, from $2.61B to $3.15B.
- What is the long-term trend for Integra LifeSciences's enterprise value?
- Over 5 years (2020 to 2025), Integra LifeSciences's enterprise value has grown at a -15.3% compound annual growth rate (CAGR), from $6.06B to $2.64B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Integra LifeSciences's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude